UPDATED May 21, 2025
Discover U.S. Pharmaceuticals & Biotech Growth Stocks that are on the NYSE and NASDAQ. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
CPIX | US$4.96 | 0% | 215.9% | US$75.3m | n/a | PS1.8x | n/a | n/a | ||
TELO | US$2.13 | -19.9% | -62.0% | US$68.2m | US$15.25 | PE-5.1x | S178.1% | n/a | ||
SLRX | US$0.78 | -10.3% | -80.2% | US$1.4m | n/a | PB22x | n/a | n/a | ||
RGC | US$415.00 | 21.0% | 7,500.7% | US$5.8b | n/a | PB657.1x | n/a | n/a | ||
KRON | US$0.67 | -7.4% | -32.9% | US$41.2m | n/a | PS4.5x | n/a | n/a | ||
SONN | US$1.20 | -7.3% | -91.4% | US$3.7m | US$20.00 | PS3.7x | n/a | n/a | ||
GALT | US$1.28 | -1.5% | -58.8% | US$81.6m | n/a | PE-1.8x | n/a | n/a | ||
GNTA | US$4.45 | 5.7% | 34.8% | US$81.4m | US$27.10 | PB5.8x | n/a | n/a | ||
SNDL | US$1.31 | 2.3% | -44.0% | US$342.2m | US$3.50 | PB0.4x | S5.5% | n/a | ||
ARMP | US$2.10 | 52.2% | -18.6% | US$81.4m | US$9.00 | PS16.2x | n/a | n/a | ||
MDCX | US$7.71 | 22.0% | n/a | US$89.3m | US$16.15 | n/a | n/a | n/a |